BWM
PFE icon

Bulltick Wealth Management’s Pfizer PFE Stock Holding History

Bulltick Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Sell
21,389
-1,470
-6% -$38.5K 0.11% 79
2026
Q1 		$642K Buy
22,859
+94
+0.4% +$2.5K 0.14% 70
2025
Q4 		$567K Sell
22,765
-400
-2% -$10.1K 0.12% 77
2025
Q3 		$590K Sell
23,165
-3,050
-12% -$75.3K 0.14% 72
2025
Q2 		$635K Sell
26,215
-113,740
-81% -$2.65M 0.16% 83
2025
Q1 		$3.55M Buy
139,955
+53,894
+63% +$1.41M 0.94% 34
2024
Q4 		$2.28M Sell
86,061
-56,571
-40% -$1.53M 0.52% 45
2024
Q3 		$4.13M Sell
142,632
-181,722
-56% -$5.3M 1% 32
2024
Q2 		$9.08M Sell
324,354
-26,530
-8% -$730K 2.24% 15
2024
Q1 		$9.74M Buy
350,884
+77,299
+28% +$2.14M 1.67% 17
2023
Q4 		$7.88M Buy
273,585
+21,340
+8% +$645K 1.79% 20
2023
Q3 		$8.37M Buy
252,245
+38,920
+18% +$1.38M 2.01% 18
2023
Q2 		$7.82M Buy
213,325
+61,559
+41% +$2.4M 1.74% 21
2023
Q1 		$6.19M Buy
+151,766
New +$6.55M 1.61% 26

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bulltick Wealth Management's PFE Position: Q2 2026 in Review

Bulltick Wealth Management reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $38.5K and leaving 21,389 shares worth $515K. The position accounts for 0.11% of the portfolio, ranked #79.

Bulltick Wealth Management first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $9.74M in Q1 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bulltick Wealth Management held 21,389 shares of Pfizer worth $515K as of Q2 2026.
  • Bulltick Wealth Management sold 1,470 Pfizer shares in Q2 2026, an estimated $38.5K.
  • Pfizer made up 0.11% of Bulltick Wealth Management's portfolio in Q2 2026, its #79 holding.
  • Bulltick Wealth Management first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • Bulltick Wealth Management's Pfizer position peaked at $9.74M in Q1 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bulltick Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.